Maximizing the diversity of participants in a phase II clinical trial of optical technologies to detect cervical neoplasia
- 31 October 2007
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 107 (1) , S208-S214
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effectiveness of strategies to recruit underrepresented populations into cancer clinical trialsClinical Trials, 2006
- Recruitment of African American and white postmenopausal women into clinical trials: the beneficial effects of soy trial experience.2006
- Participant recruitment and motivation for participation in optical technology for cervical cancer screening research trialsGynecologic Oncology, 2005
- Optical technologies for cervical neoplasia: update of an NCI program project grant.2005
- Participation in Cancer Clinical TrialsJAMA, 2004
- Why patients don’t take part in cancer clinical trials: an overview of the literatureEuropean Journal of Cancer Care, 2003
- Optical spectroscopy for detection of neoplasiaCurrent Opinion in Chemical Biology, 2002
- Participation of Minorities and Women in Clinical Cancer ResearchAnnals of Epidemiology, 2000
- Patientsʼ Attitudes and Comfort Levels Regarding Medical Studentsʼ Involvement in Obstetrics—Gynecology Outpatient ClinicsAcademic Medicine, 2000
- Technology assessment in medicineAcademic Medicine, 1992